Search

everythinglearnresearchcommunity

for

Search:↓

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Multiple courses of pulse corticosteroid therapy improve hair growth in alopecia areata patients with minimal side effects.

Group behavior therapy reduces hair-pulling symptoms more than supportive therapy but has limited long-term effectiveness.

A specific gene mutation causes varying hair loss severity in a Pakistani family.

Higher cannabis exposure may lead to increased hair loss.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Trichoscopy effectively diagnoses and assesses hair loss severity in androgenetic alopecia and alopecia areata.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

Chronic exposure to sunlight may worsen male pattern baldness and protecting the scalp from the sun could slow it down.

Plasma Rich in Growth Factors may help reduce hair loss in Frontal Fibrosing Alopecia.

Mange in guinea pigs can be cured with gamma benzene hexachloride washes.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

The document concludes that individualized reconstruction plans are essential for improving function and appearance after head and neck burns.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

More severe hair loss in alopecia areata greatly impacts patients and caregivers.

Patients with the same vitamin D receptor mutation showed different symptoms due to other factors.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

Higher social status is linked to earlier diagnosis and better treatment results for Frontal Fibrosing Alopecia in women.

Androgenetic alopecia is the only hair loss condition with specific diagnostic criteria in trichoscopy.

Allergen-specific immunotherapy can significantly improve hair loss and dermatitis symptoms in severe cases.

Alopecia areata significantly affects emotional well-being and quality of life, especially in younger adults.

Some people with alopecia areata, a hair loss condition, get better within a year without treatment, but it can happen again.

Dissecting Cellulitis of the Scalp is more common in young men and often associated with head and neck acne.